6-Butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carboxylic acid pentafluorophenyl ester → (+/-)-cis-4-({[6-Butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carbonyl]-amino}-methyl)-3-fluoro-piperidine-1-carboxylic acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][C@H:11]([CH2:14][NH2:15])[C@H:10]([F:16])[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].FC1C([O:24][C:25]([C:27]2[N:28]=[N:29][C:30]([CH2:46][CH2:47][CH2:48][CH3:49])=[C:31]([C:33]3[CH:38]=[CH:37][C:36]([O:39][CH:40]4[CH2:45][CH2:44][CH2:43][CH2:42][CH2:41]4)=[CH:35][CH:34]=3)[CH:32]=2)=O)=C(F)C(F)=C(F)C=1F>ClCCl>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][C@H:11]([CH2:14][NH:15][C:25]([C:27]2[N:28]=[N:29][C:30]([CH2:46][CH2:47][CH2:48][CH3:49])=[C:31]([C:33]3[CH:38]=[CH:37][C:36]([O:39][CH:40]4[CH2:41][CH2:42][CH2:43][CH2:44][CH2:45]4)=[CH:35][CH:34]=3)[CH:32]=2)=[O:24])[C@H:10]([F:16])[CH2:9]1)=[O:7])([CH3:4])([CH3:2])[CH3:3]Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirred solution of (±)-cis-4-aminomethyl-3-fluoro-piperidine-1-carboxylic acid tert-butyl ester (0.65 mmol, 150 mg) in dichloromethane (3 mL) was added 6-butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carboxylic acid pentafluorophenyl ester (Example 93, 0.75 mmol, 400 mg) and TEA (1.3 mmol, 0.2 mL). After stirring the reaction at room temperature for 8 h, dichloromethane (5 mL) was added. The reaction was washed with saturated sodium bicarbonate solution (5 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated. Crude product was purified using hexane:ethyl acetate on 12 g normal phase ISCO flash column to provide (±)-cis-4-({[6-butyl-5-(4-cyclohexyloxy-phenyl)-pyridazine-3-carbonyl]-amino}-methyl)-3-fluoro-piperidine-1-carboxylic acid tert-butyl ester.
Workup
- customthe reaction at room temperature for 8 h
- washThe reaction was washed with saturated sodium bicarbonate solution (5 mL)
- dry with materialThe organic layer was dried over anhydrous sodium sulfate
- concentrationconcentrated
- customCrude product was purified
Sources & evidence
- ORD record
- ord-85b3bb4c623240c491ecc6b59081b4da
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08431575B2
Reaction notes
Loading…